Uncover key drivers, emerging technologies, and competitive movements shaping the in-vitro lung model market from 2026–2035 with trusted insights from The Business Research Company

How much is the In-Vitro Lung Model Market valued at in 2026, and what valuation is forecast for 2030?

The in-vitro lung model market has experienced substantial expansion in recent years. It is projected to grow from $0.54 billion in 2025 to $0.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 21.0%. This market’s historical growth can be attributed to several factors, including the limitations of animal models in respiratory research, the longstanding use of two-dimensional lung cell cultures, a rise in respiratory disease research activity, the expansion of academic lung biology research, and the early adoption of organoid-based research methods.

The in-vitro lung model market is anticipated to experience substantial growth over the next few years. It is forecast to expand to $1.29 billion by 2030, achieving a compound annual growth rate (CAGR) of 18.6%. This projected growth stems from several factors, including an increasing need for predictive preclinical lung models, a heightened focus on reducing animal experimentation, the expansion of respiratory drug development pipelines, growing investment in advanced in-vitro research tools, and the demand for more physiologically relevant lung disease models. Prominent trends throughout the forecast period include the increasing incorporation of three-dimensional lung models in drug research, the rising utilization of lung-on-a-chip platforms for disease modeling, a growing preference for human-relevant in-vitro lung testing systems, the broadening application of in-vitro lung models in toxicology and safety studies, and greater integration of these models into preclinical research pipelines.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Drivers Are Influencing The Growth Of The In-Vitro Lung Model Market?

The expanding volume of clinical investigations is anticipated to fuel the future expansion of the in vitro lung model market. These studies represent scientific inquiries carried out to assess the security, efficacy, and results of novel medical therapies, pharmaceuticals, or diagnostic instruments in human subjects. The escalating count of clinical studies stems from increasing healthcare requirements, a heightened desire for sophisticated medical interventions, and the quest for pioneering remedies for intricate health issues. The in vitro lung model market facilitates clinical research through the provision of regulated platforms that facilitate drug screening, toxicity assessment, disease simulation, and the examination of biological responses specific to the lungs. As an illustration, in January 2024, data from ClinicalTrials.gov, a US-based clinical trial registry, indicated that 477,230 clinical trials were registered globally by the end of 2023, which signifies an increment from the 437,508 trials documented in 2022. Consequently, the uptick in clinical studies serves as a primary impetus for the in vitro lung model market.

How Is The In-Vitro Lung Model Market Organized Into Various Segments?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Which Trends Are Influencing The Development Of The In-Vitro Lung Model Market?

Leading companies in the in vitro lung model market are concentrating on developing advanced 3D respiratory tissue models to enhance physiological relevance, improve predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model is defined as a laboratory-grown three-dimensional structure comprising primary or specialized respiratory cells cultured in environments that enable them to emulate the architecture and function of human airway tissues, including mucus production, ciliary movement, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, unveiled EpiNasal, a 3D respiratory tissue model developed from primary human nasal epithelial cells that mimics functional aspects of nasal epithelium such as goblet cells, active tight junctions, and beating cilia, offering researchers a highly pertinent platform for assessing the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

Who Are The Major Companies Operating In The In-Vitro Lung Model Market?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized In-Vitro Lung Model Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Browse Through More Reports Similar to the Global In-Vitro Lung Model Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Lung Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Pulmonary Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.